These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 30521881)
1. New insights on the regulation of cancer cachexia by N-3 polyunsaturated fatty acids. Gorjao R; Dos Santos CMM; Serdan TDA; Diniz VLS; Alba-Loureiro TC; Cury-Boaventura MF; Hatanaka E; Levada-Pires AC; Sato FT; Pithon-Curi TC; Fernandes LC; Curi R; Hirabara SM Pharmacol Ther; 2019 Apr; 196():117-134. PubMed ID: 30521881 [TBL] [Abstract][Full Text] [Related]
2. Fish oil supplementation in the treatment of cachexia in pancreatic cancer patients. Brown TT; Zelnik DL; Dobs AS Int J Gastrointest Cancer; 2003; 34(2-3):143-50. PubMed ID: 15361649 [TBL] [Abstract][Full Text] [Related]
3. Mechanism of lipid mobilization associated with cancer cachexia: interaction between the polyunsaturated fatty acid, eicosapentaenoic acid, and inhibitory guanine nucleotide-regulatory protein. Tisdale MJ Prostaglandins Leukot Essent Fatty Acids; 1993 Jan; 48(1):105-9. PubMed ID: 8380931 [TBL] [Abstract][Full Text] [Related]
4. Effects of eicosapentaenoic and docosahexaenoic n-3 fatty acids from fish oil and preferential Cox-2 inhibition on systemic syndromes in patients with advanced lung cancer. Cerchietti LC; Navigante AH; Castro MA Nutr Cancer; 2007; 59(1):14-20. PubMed ID: 17927497 [TBL] [Abstract][Full Text] [Related]
5. Omega-3 polyunsaterated fatty acids improve quality of life and survival, but not body weight in cancer cachexia: A systematic review and meta-analysis of controlled trials. Jin X; Xu XT; Tian MX; Dai Z Nutr Res; 2022 Nov; 107():165-178. PubMed ID: 36283229 [TBL] [Abstract][Full Text] [Related]
6. A high ratio of dietary n-3/n-6 polyunsaturated fatty acids improves obesity-linked inflammation and insulin resistance through suppressing activation of TLR4 in SD rats. Liu HQ; Qiu Y; Mu Y; Zhang XJ; Liu L; Hou XH; Zhang L; Xu XN; Ji AL; Cao R; Yang RH; Wang F Nutr Res; 2013 Oct; 33(10):849-58. PubMed ID: 24074743 [TBL] [Abstract][Full Text] [Related]
7. Historical perspective and potential use of n-3 fatty acids in therapy of cancer cachexia. Karmali RA Nutrition; 1996 Jan; 12(1 Suppl):S2-4. PubMed ID: 8850210 [TBL] [Abstract][Full Text] [Related]
8. Eicosapentaenoic acid in cancer improves body composition and modulates metabolism. Pappalardo G; Almeida A; Ravasco P Nutrition; 2015 Apr; 31(4):549-55. PubMed ID: 25770317 [TBL] [Abstract][Full Text] [Related]
10. The effects of omega-3 polyunsaturated fatty acids on cardiac rhythm: a critical reassessment. Billman GE Pharmacol Ther; 2013 Oct; 140(1):53-80. PubMed ID: 23735203 [TBL] [Abstract][Full Text] [Related]
11. n-3 Polyunsaturated fatty acids for the management of alcoholic liver disease: A critical review. Wang M; Ma LJ; Yang Y; Xiao Z; Wan JB Crit Rev Food Sci Nutr; 2019; 59(sup1):S116-S129. PubMed ID: 30580553 [TBL] [Abstract][Full Text] [Related]
12. Protective Effects of Omega-3 Fatty Acids in Cancer-Related Complications. Freitas RDS; Campos MM Nutrients; 2019 Apr; 11(5):. PubMed ID: 31035457 [TBL] [Abstract][Full Text] [Related]
14. 4-Hydroxyhexenal and 4-hydroxynonenal are mediators of the anti-cachectic effect of n-3 and n-6 polyunsaturated fatty acids on human lung cancer cells. Muzio G; Ricci M; Traverso N; Monacelli F; Oraldi M; Maggiora M; Canuto RA Free Radic Biol Med; 2016 Oct; 99():63-70. PubMed ID: 27480845 [TBL] [Abstract][Full Text] [Related]
15. Health benefits of n-3 polyunsaturated fatty acids: eicosapentaenoic acid and docosahexaenoic acid. Siriwardhana N; Kalupahana NS; Moustaid-Moussa N Adv Food Nutr Res; 2012; 65():211-22. PubMed ID: 22361189 [TBL] [Abstract][Full Text] [Related]
16. Molecular therapeutic strategies targeting pancreatic cancer induced cachexia. Yakovenko A; Cameron M; Trevino JG World J Gastrointest Surg; 2018 Dec; 10(9):95-106. PubMed ID: 30622678 [TBL] [Abstract][Full Text] [Related]
17. Omega-3 Polyunsaturated Fatty Acids in Critical Illness: Anti-Inflammatory, Proresolving, or Both? Molfino A; Amabile MI; Monti M; Muscaritoli M Oxid Med Cell Longev; 2017; 2017():5987082. PubMed ID: 28694914 [TBL] [Abstract][Full Text] [Related]
18. Cancer cachexia and tumor growth reduction in Walker 256 tumor-bearing rats supplemented with N-3 polyunsaturated fatty acids for one generation. Togni V; Ota CC; Folador A; Júnior OT; Aikawa J; Yamazaki RK; Freitas FA; Longo R; Martins EF; Calder PC; Curi R; Fernandes LC Nutr Cancer; 2003; 46(1):52-8. PubMed ID: 12925304 [TBL] [Abstract][Full Text] [Related]
19. n-3 polyunsaturated fatty acids: the potential role for supplementation in cancer. Murphy RA; Mourtzakis M; Mazurak VC Curr Opin Clin Nutr Metab Care; 2012 May; 15(3):246-51. PubMed ID: 22366922 [TBL] [Abstract][Full Text] [Related]
20. Overexpression and hyperactivity of breast cancer-associated fatty acid synthase (oncogenic antigen-519) is insensitive to normal arachidonic fatty acid-induced suppression in lipogenic tissues but it is selectively inhibited by tumoricidal alpha-linolenic and gamma-linolenic fatty acids: a novel mechanism by which dietary fat can alter mammary tumorigenesis. Menendez JA; Ropero S; Mehmi I; Atlas E; Colomer R; Lupu R Int J Oncol; 2004 Jun; 24(6):1369-83. PubMed ID: 15138577 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]